Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BLRX will rise by +7.75% over the next 2 Weeks and hit $2.96 by Thursday, May 14, 2026. In that time frame, BLRX's share price is expected to range between $2.85 and $3.08.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 14, 2026 | 2.85 | 2.96 | 3.08 |
| May 13, 2026 | 2.84 | 2.96 | 3.07 |
| May 12, 2026 | 2.90 | 3.01 | 3.13 |
| May 11, 2026 | 2.80 | 2.91 | 3.02 |
| May 8, 2026 | 2.90 | 3.00 | 3.11 |
| May 7, 2026 | 2.84 | 2.94 | 3.05 |
| May 6, 2026 | 2.83 | 2.93 | 3.05 |
| May 5, 2026 | 2.88 | 2.99 | 3.10 |
| May 4, 2026 | 2.77 | 2.88 | 2.99 |
| May 1, 2026 | 2.87 | 2.98 | 3.09 |
BLRX shares rose +4.12% in Friday, May 1, 2026's trading session, rising from a previous close of $2.75 to move at $2.86. The stock demonstrated notable intraday movement (see BLRX's key stats for a full breakdown), fluctuating between $2.73 and $2.86, a +4.88% trading range. While recent weeks have seen some volatility, BLRX has managed to secure a +19.80% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 77.28K shares changing hands, 10.64K more than the previous session. This amounted to $221.25K in total market activity.
Will BLRX Continue Its Upward Trend?
According to analyst ratings and projections for BLRX, BioLineRx Ltd. shares are anticipated to increase by +6.98%, potentially reaching $3.08 per share by May 14, 2026. Short-term technical indicators currently suggest a neutral sentiment for BLRX. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the BLRX stock forecast, now is a good time to buy BLRX stock because its current trading price is -3.37% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on BLRX covering social and institutional perspectives.
BLRX Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BLRX's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 58.88% to 64.95%) suggest the stock is showing bullish momentum with some volatility. The 50-day RSI, at 50.94%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 46.20%, maintains a neutral outlook for the long term. Insights into BLRX's shareholder base show how institutional investors are positioning themselves during these momentum shifts
BioLineRx Short-Term Forecasts
BLRX Forecast For Next 5 Days
Our algorithm anticipates BioLineRx (BLRX) stock could hit $2.09 by May 08, 2026. This represents a -27.12% fall from today's price, following a -1.05% change over the past five days.
BLRX Forecast For Next 30 Days
Based on analysis of market trends, the outlook for BioLineRx Ltd. (BLRX) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $2.09, which would mean a -27.00% decrease from the current price of $2.86. Projections for this period range from a high of $2.55 to a low of $1.69.
BLRX Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for BioLineRx's price over the next three months point to a rise. BLRX stock is expected to peak at $6.34 on Jun 09, 2026 before potentially dipping to $1.96 on Jul 10, 2026. On average, BLRX is likely to trade around $4.39 in the coming 90 days.
BioLineRx Stock Forecast 2025
Based on our predictive models, BioLineRx (BLRX) is expected to trade between $0.00 and $6.51 throughout 2026. This would result in an average price of $4.29, potentially offering investors a +49.83% return from current levels.
BioLineRx Ltd. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, BioLineRx Ltd. (BLRX) is positioned to show a strong performance in May 2026. The price is predicted to move between $2.28 and $6.18, settling at an average of $4.29. This could translate to a +49.83% gain.
June 2026
Based on current market signals, BioLineRx Ltd. is projected to trend june 2026. We forecast a trading range from $2.98 to $6.34, with a likely average price of $4.96. Investors could expect a potential return of +73.23%.
July 2026
Our predictive algorithms indicate BioLineRx Ltd. stock may see a shift in July 2026. The expected range spans $1.96–$5.70, with an average target of $3.94. This represents a positive outlook and a possible gain of +37.61%.
August 2026
Analyzing established trends, BioLineRx Ltd. looks set to move in August 2026. Projections place the stock between $3.44 and $6.51, averaging around $5.12. This suggests a +78.82% gain from current levels.
September 2026
Market indicators suggest BioLineRx Ltd. could experience notable changes during September 2026. Prices could fluctuate within $1.85 to $6.33, with a midpoint forecast of $4.40. The stock might deliver a +53.67% gain.
October 2026
Forecasting for October 2026, models estimate that BioLineRx Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $1.63 and $4.96, averaging $3.70. This signals a positive trajectory with potential returns around +29.23%.
November 2026
According to our latest forecast models, BioLineRx Ltd. (BLRX) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.86 and $5.15, settling at an average of $4.17. This could translate to a +45.64% gain.
December 2026
Based on current market signals, BioLineRx Ltd. is projected to trend december 2026. We forecast a trading range from $0.00 to $4.18, with a likely average price of $3.83. Investors could expect a potential return of +33.77%.
January 2027
Our predictive algorithms indicate BioLineRx Ltd. stock may see a shift in January 2027. The expected range spans $0.00–$3.94, with an average target of $4.69. This represents a positive outlook and a possible gain of +63.80%.
February 2027
Analyzing established trends, BioLineRx Ltd. looks set to move in February 2027. Projections place the stock between $0.00 and $2.34, averaging around $2.95. This suggests a +3.03% gain from current levels.
March 2027
Market indicators suggest BioLineRx Ltd. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $0.96, with a midpoint forecast of $3.38. The stock might deliver a +18.05% gain.
April 2027
Forecasting for April 2027, models estimate that BioLineRx Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.00, averaging $2.88. This signals a positive trajectory with potential returns around +0.59%.
BLRX's history of dividends and stock splits also plays a role in long-term investor confidence.

